Австралія - англійська - Department of Health (Therapeutic Goods Administration)

correvio australia pty ltd - tirofiban hydrochloride -

Ізраїль - англійська - Ministry of Health

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Панама - англійська - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

aspen labs, s.a. de c.v. - tirofibÁn (clorhidrato monohidrato) - tirofibÁn (clorhidrato monohidrato)....0.25 mg

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - tirofiban hydrochloride monohydrate 0.05618 mg/ml equivalent to 0.05 mg/ml tirofiban - solution for infusion - 0.05 mg/ml - active: tirofiban hydrochloride monohydrate 0.05618 mg/ml equivalent to 0.05 mg/ml tirofiban excipient: citric acid hydrochloric acid sodium chloride sodium citrate dihydrate sodium hydroxide water for injection

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

iroko cardio (uk) ltd - tirofiban hydrochloride monohydrate - solution for infusion - 0.05mg/ml mg/ml

Ізраїль - англійська - Ministry of Health

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Мальта - англійська - Medicines Authority

correvio (uk) limited - tirofiban hydrochloride monohydrate 50 µg/ml - solution for infusion

Бахрейн - англійська - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - tirofiban hydrochloride monohydrate - solution for infusion - 0.25